Published online November 1, 2004
PEDIATRICS Vol. 114 No. 5 November 2004, pp. 1366-1367 (doi:10.1542/peds.2004-1661)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Related articles in Pediatrics
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quinn, G. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Quinn, G. E.
Related Collections
Right arrow Ophthalmology

The Pediatric Eye Disease Investigator Group Report May Be Too Optimistic About Efficacy of Treatment: In Reply

Graham E. Quinn, MD, MSCE
Children's Hospital of Philadelphia
University of Pennsylvania School of Medicine
Philadelphia, PA 19104

Roy W. Beck, MD, PhD
Jaeb Center for Health Research
Tampa, FL 33647

Michael X. Repka, MD
Wilmer Institute
Johns Hopkins University School of Medicine
Baltimore, MD 21287

Jonathan M. Holmes, BM, BCh
Department of Ophthalmology
Mayo Clinic College of Medicine
Rochester, MN 55905

on Behalf of Pediatric Eye Disease Investigator Group
The first 20% of the full text of this article appears below.

In Reply.—

Dr Lempert's recent letter describes similar issues to those he has raised in previous letters to the editor. We have responded to these issues in the past and will reiterate our responses. The Amblyopia Treatment Studies (ATS) are a series of randomized, clinical trials designed to answer questions about the optimal management of amblyopia.1–9 The studies are conducted by the Pediatric Eye Disease Investigator Group (PEDIG), a large group of pediatric ophthalmologists and optometrists based in both university and community settings.10,11 Dr Lempert contends that a significant weakness of the ATS is . . . [Full Text of this Article]


Related articles in Pediatrics:

The Pediatric Eye Disease Investigator Group Report May Be Too Optimistic About Efficacy of Treatment
Philip Lempert
Pediatrics 2004 114: 1366. [Extract] [Full Text]